Mediso completes technology transfer of novel MRI spectrometer

Mediso completes technology transfer of novel MRI spectrometer
News provided by
Share this article
Share this article
BUDAPEST, Hungary, April 26, 2021 /PRNewswire/ -- Mediso Medical Imaging Systems today announced that it has completed the technology transfer of the new Cameleon4™ MRI spectrometer developed by RS
2D (Strasbourg, France). Following the IP transfer, the new console is seamlessly integrated into the nanoScan
® cryogen-free 3T and 7T MRI product line resulting in superior imaging performance. Financial terms of the agreement were not disclosed.
Mediso nanoScan® PET/MRI 7T
For the past seven years Mediso and RS
2D partnered in a technology license and commercial agreement to deliver the new line of nanoScan

Related Keywords

Canada , ,Preclinical Product Development At Mediso ,Nanalysis Corp ,Preclinical Product Development ,Medical Imaging ,Mediso Medical Imaging Systems ,Health Care Amp Hospitals ,Medical Equipment ,Medical Pharmaceuticals ,Stem Science ,Tech ,Engineering ,Path ,Computer Amp Electronics ,Computer Software ,Licensing ,New Products Amp Services ,கனடா ,மருத்துவ இமேஜிங் ,ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் ,மருத்துவ மருந்துகள் ,தண்டு அறிவியல் ,அத் ,கணினி ஆம்ப் மின்னணுவியல் ,கணினி மென்பொருள் ,உரிமம் ,புதியது ப்ராடக்ட்ஸ் ஆம்ப் சேவைகள் ,